Cases

OPINION AND ORDER SHIRA A. SCHEINDLIN, UNITED STATES DISTRICT JUDGE. I. INTRODUCTION On November 25, 2013, this Court issued an Opinion and Order (the “November 25 Opinion” granting summary judgment, inter alia, as to counterclaim-defendants’ patent non-infringement claims. Because I granted summary judgment on the patent non-infringement claims, I held that counterclaim-defen

OPINION BY FORD ELLIOTT, P.J.E.: Timothy Stange ("Stange"), plaintiff in the court below, and defendants, Janssen Pharmaceuticals, Inc. ("Janssen"), Johnson & Johnson, and Janssen Research & Development, LLC, 1 have taken cross-appeals from the judgment entered in favor of Stange in the amount of $535,106.17. Stange,

ORDER GRANTING JANSSEN PHARMACEUTICALS, INC. AND JOHNSON & JOHNSON’S MOTION TO DISMISS JON P. McCALLA, UNITED STATES DISTRICT JUDGE Before the Court is Defendants Janssen Pharmaceuticals, Inc. and Johnson & Johnson’s (“Defendants”) Motion to Dismiss, filed February 12, 2016. (ECF No. 18). For the following reasons, Defendants’ Motion to Dismiss is GRANTED. Accordingly, the Court dismisses al

GUIDRY, Justice. _JjThe Attorney General for the State of Louisiana brought an action against the defendant pharmaceutical companies alleging inter alia certain violations of the Louisiana Medical Assistance Programs Integrity Law (“MAPIL”). Following trial in September 2010, the district court entered a judgment upon the jury’s verdict in favor of the Attorney General finding the defendants’ alleged misconduct in ma

FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT UNITED STATES ex rel. ALEXANDER No. 18-55643 VOLKHOFF, LLC, Plaintiff-Appellant, * D.C. No. 2:16-cv-06997- v. RGK-RAO JANSSEN PHARMACEUTICA N.V.; JANSSEN PHARMACEUTICALS, INC.; OPINION JANSSEN RESEARCH AND DE

FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT UNITED STATES ex rel. ALEXANDER No. 18-55643 VOLKHOFF, LLC, Plaintiff-Appellant, * D.C. No. 2:16-cv-06997- v. RGK-RAO JANSSEN PHARMACEUTICA N.V.; JANSSEN PHARMACEUTICALS, INC.; OPINION JANSSEN RESEARCH AND DE

Wallach, Circuit Judge. *1066 Appellants BTG International Limited et al. ("Appellants") sued Appellees Amneal Pharmaceuticals LLC et al. ("Appellees") in the U.S. District Court for the District of New Jersey ("District Court"), asserting that Appellees' Abbreviated New Drug Applicatio

805 F.Supp.2d 133 (2011) Bentley A. HOLLANDER, Plaintiff, v. ORTHO-McNEIL-JANSSEN PHARMACEUTICALS, INC., Defendant. Civil Action No. 10-00836. United States District Court, E.D. Pennsylvania. April 5, 2011. *134 Aaron J. Freiwald, Layser & Freiwald PC, Philadelphia, PA, for Plaintiff. Alfred W. Putnam, Jr., Andrea L. D

456 F.Supp.2d 644 (2006) JANSSEN PHARMACEUTICA N.V., and Janssen Pharmaceutica Products, L.P., Plaintiffs, v. MYLAN PHARMACEUTICALS., INC., Defendants. Janssen Pharmaceutica N.V., and Janssen Pharmaceutica Products, L.P., Plaintiffs, v. Dr. Reddy's Laboratories, Ltd., and Dr. Reddy's Laboratories, Inc., Defendants. Civil Action Nos. 03-6220 (JCL), 03-6185(JCL). United States District Court,

784 F.Supp.2d 508 (2011) DISTRICT 1199P HEALTH AND WELFARE PLAN, et al., Plaintiffs, v. JANSSEN, L.P., et al., Defendants. Civil Action No. 10-2021 (FLW). United States District Court, D. New Jersey. March 21, 2011. *512 Brian J. McCormick, Jr., Sheller, PC, Philadelphia, PA, Rosalee B. Connell, Finkelstein Thompson LLP, Washingt

[Regarding Application of the Court's Prior Rulings on Manifestation, Incidental Damages (Lost Time), and Unjust Enrichment to All Remaining Jurisdictions in Dispute (MDL Order No. 131 Issues) ] JESSE M. FURMAN, United States District Judge INTRODUCTION... 274 LEGAL STANDARDS... 275 DISCUSSION... 275 A. Manifestation... 276

609 F.Supp.2d 1282 (2009) EXHIBIT ICONS, LLC et al, Plaintiffs, v. XP COMPANIES, LLC, et al, Defendants. No. 07-80824-CIV. United States District Court, S.D. Florida. March 26, 2009. *1287 Mark Robert Vogel, Mark R. Vogel, P.A., Hollywood, FL, Steven Frederick Samilow, Weston, FL, for Plaintiffs. Steven Neil Lippman, Roths

COURT OF APPEALS EIGHTH DISTRICT OF TEXAS EL PASO, TEXAS § WHATABURGER RESTAURANTS No. 08-13-00280-CV LLC, § Appeal from Appellant, §

KEVIN MCNULTY, United States District Judge These are consolidated Hatch-Waxman actions for infringement of United States Patent No. 8,822,438 ("the '438 patent") brought by Janssen Biotech, Inc.; Janssen Oncology, Inc.; Janssen Research & Development, LLC (collectively, "Janssen"); and BTG International Ltd. ("BTG"). Janssen and BTG co-own the '438 patent. The '438 patent contains twenty claims covering methods for the treatm

2026 IL App (2d) 250055 No. 2-25-0055 Opinion filed July 9, 2026 IN THE APPELLATE COURT OF ILLINOIS SECOND DISTRICT MIRAMAR CAPITAL, LLC, and ROBERT KALMAN, Plaintiffs-Appellees and Cross- Appellants,

84 F.Supp.2d 759 (2000) The UNIVERSITY OF WEST VIRGINIA BOARD OF TRUSTEES, Plaintiff, v. Kurt L. VanVOORHIES, Defendant, v. West Virginia University Research Corporation, et al. No. CIV. A. 1:97-CV-144. United States District Court, N.D. West Virginia, Martinsburg Division. February 17, 2000. *760 Andrew G. Fusco, The Fus

MEMORANDUM OPINION AND ORDER JAMES O. BROWNING, UNITED STATES DISTRICT JUDGE THIS MATTER comes before the Court on: (i) Defendant Builders Trust of New México’s Partial Motion to Dismiss, filed November 17, 2016 (Doc. 4)(“MTD”); and (ii) Plaintiffs Motion for Judgment on the Pleadings, filed December 6, 2016 (Doc. 10)(“Motion for Judgment”). The Court held a hearing on'January 23, 2017." The primary is

731 F.Supp.2d 348 (2010) ELI LILLY AND COMPANY, Plaintiff, v. ACTAVIS ELIZABETH LLC, Glenmark Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Sandoz Inc., Mylan Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Teva Pharmaceuticals USA, Inc., Synthon Laboratories, Inc., Zydus Pharmaceuticals, USA, Inc., Defendants. Civ. No. 07-CV-3770 (DMC)(JAD). United States District Court, D. New J

OPINION Ashely M. Chan, United States Bankruptcy Judge TABLE OF CONTENTS I. Introduction... 136 II. Facts and Procedural History... 136 A. The Debtor... 137 B. The Chesapeake Bank Factoring Agreement... 137 C. So Real Brands, LLC... 138 D. The Debtor’s Assets... 138

LOUGHRY, Justice: This matter is before this Court upon a June 9, 2017, order of the United States *856Court of Appeals for the Fourth Circuit certifying the following question: Whether West Virginia law permits a claim of failure to warn and negligent misrepresentation against a branded drug manufacturer when the dr